# A nurse is caring for a patient with severe poison ivy dermatitis. Which medication would be the most appropriate first-line treatment for this patient's condition? > source: MyMerci (mymerci.kr) > url: https://mymerci.kr/pages/nclex_q.php?qn_id=543521 > language: ko > subject: Pharmacology ## 문제 A nurse is caring for a patient with severe poison ivy dermatitis. Which medication would be the most appropriate first-line treatment for this patient's condition? ## 보기 1. Topical antihistamine cream (diphenhydramine) 2. Oral antibiotic (cephalexin) 3. Oral corticosteroid (prednisone) **✔ 정답** 4. Topical anesthetic (lidocaine gel) **정답: 3** ## 해설 Oral corticosteroids like prednisone are first-line for severe, extensive poison ivy dermatitis due to potent anti-inflammatory effects. Topical antihistamines, antibiotics, and anesthetics are not primary treatments for this condition. ## 심화 해설 Understanding the Condition: Severe Poison Ivy Dermatitis The patient in this scenario is experiencing a severe form of allergic contact dermatitis (ACD), a type IV hypersensitivity reaction. This is not an immediate, histamine-driven allergy (Type I), but a delayed, cell-mediated immune response. Upon first exposure to the plant's oil, urushiol, the body becomes sensitized. With subsequent exposures, urushiol penetrates the skin and binds to skin proteins, forming a complex that is recognized by T-lymphocytes. This triggers a powerful inflammatory cascade, leading to the characteristic erythematous, pruritic, and blistering rash. The severity described as "severe poison ivy dermatitis" indicates a widespread, intensely symptomatic reaction that goes beyond what a mild, localized rash would present. Research into urushiol-induced ACD confirms that this process involves complex immune mechanisms and inflammatory pathways, such as the Erk/CCL2 pathway, which contributes to the intense pruritus [1]. Analyzing the Treatment Options To determine the most appropriate first-line treatment, we must evaluate how each option addresses the underlying pathophysiology of a severe type IV hypersensitivity reaction. - Option 1: Topical antihistamine cream (diphenhydramine) is ineffective for this condition. The pruritus in ACD is not primarily mediated by histamine release from mast cells, as seen in a Type I hypersensitivity reaction [3]. Instead, it is driven by T-cell activity and the release of other inflammatory mediators. Furthermore, topical diphenhydramine can be a sensitizer itself, potentially causing a secondary ACD and worsening the clinical picture. - Option 2: Oral antibiotic (cephalexin) is not indicated for the primary inflammatory process. Cephalexin is an antibacterial agent. It would only be appropriate if a secondary bacterial infection, such as impetigo from scratching, were present. The initial presentation of severe poison ivy dermatitis is an inflammatory condition, not an infectious one. - Option 4: Topical anesthetic (lidocaine gel) provides only temporary, symptomatic relief by numbing the skin's surface. It does nothing to halt the underlying immune-mediated inflammatory cascade. Similar to topical antihistamines, topical anesthetics can also cause allergic contact dermatitis, potentially complicating the condition. - Option 3: Oral corticosteroid (prednisone) is the correct choice. Corticosteroids are potent anti-inflammatory agents that work by suppressing multiple steps in the immune response. They inhibit the activity of T-lymphocytes, reduce the release of inflammatory cytokines, and stabilize lysosomal membranes, effectively shutting down the cell-mediated reaction causing the dermatitis. For a severe, widespread case of poison ivy, a systemic agent is required to control the inflammation from within, as topical steroids are often impractical and insufficient for large body surface areas. Clinical Reasoning and First-Line Therapy The clinical presentation of a severe, blistering rash with linear streaks, as can be seen with urushiol and even related plants like Virginia creeper, confirms a diagnosis of severe ACD [2]. The cornerstone of managing a severe, systemic type IV hypersensitivity reaction is systemic corticosteroid therapy. Oral prednisone is the first-line treatment because it directly targets the pathological immune mechanism, not just the symptoms. The goal is to rapidly suppress the T-cell-mediated inflammation to provide relief and prevent progression. Treatment typically involves a tapering course over two to three weeks to prevent a rebound flare-up of the dermatitis. While novel treatments exploring anti-inflammatory and immunomodulatory pathways are under investigation for pruritus relief, such as the use of paeoniflorin, systemic corticosteroids remain the established and evidence-based standard of care for severe presentations [1].References (research sources) - [1]Paeoniflorin alleviates urushiol-induced pruritus in mice by inhibiting Erk/CCL2 pathway.Research articleYou H, Tai L, Li Y, Qi T, Yang Y, Zhu C, Qiu X, Yu G, Zhou Y, Tang Z. (2026) · DOI: 10.1016/j.ejphar.2026.178604 - [2]Contact Dermatitis From Exposure to Virginia Creeper (Parthenocissus quinquefolia): A Deviation From the Saying "Leaves of Three, Let It Be".Research articleFrase DM, Bannon S. (2025) · DOI: 10.7759/cureus.86240 - [3]Type I Hypersensitivity ReactionResearch articleAbbas M, Goldin J. (2026) ## 임상 시나리오 Severe Poison Ivy: Steroid UseFirst-line systemic therapy for widespread type IV hypersensitivity Severe allergic contact dermatitis from poison ivy is a type IV hypersensitivity reaction driven by T-cells, not histamine. For widespread or severe cases, oral corticosteroids like prednisone are first-line to suppress the systemic inflammatory cascade. A typical adult regimen is 0.5 to 1 mg/kg/day of prednisone, tapered over 2 to 3 weeks to prevent rebound dermatitis. Short, 6-day dose packs are often insufficient and associated with relapse. CautionTopical antihistamines are ineffective and may cause sensitization. Do not confuse the mechanism with type I reactions where antihistamines are appropriate. Ensure no contraindications to systemic steroids exist. ## 핵심 개념 - **Allergic Contact Dermatitis (ACD)** — A type IV delayed hypersensitivity reaction triggered by skin contact with an allergen like urushiol, leading to a T-cell-mediated inflammatory rash. - **Type IV Hypersensitivity** — A delayed cell-mediated immune response involving T-lymphocytes rather than antibodies, distinct from immediate histamine-mediated type I reactions. - **Urushiol** — The oily resin found in poison ivy, oak, and sumac that penetrates the skin and binds to proteins, initiating the sensitization and allergic response. - **Prednisone** — A systemic corticosteroid that suppresses the overall inflammatory and immune response, making it the first-line treatment for severe, widespread ACD. ## 같은 주제 문제 - [A nurse is caring for a client who developed severe contact dermatitis from poison ivy exp…](https://mymerci.kr/pages/nclex_q.php?qn_id=543522) - [A nurse is caring for a client who developed severe contact dermatitis from poison ivy exp…](https://mymerci.kr/pages/nclex_q.php?qn_id=543523) --- More free questions: [기출문제](https://mymerci.kr/) _학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._